Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Science

Volumn 368, Issue 6493, 2020, Pages 860-868

  Kissler, Stephen M ^a   Tedijanto, Christine ^a   Goldstein, Edward ^a   Grad, Yonatan H ^a   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA SET; DISEASE TRANSMISSION; IMMUNITY; VIRUS;

ARTICLE; CORONAVIRIDAE; CORONAVIRUS DISEASE 2019; DEATH; DISEASE DURATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIC; HERD IMMUNITY; HUMAN; HUMAN CORONAVIRUS HKU1; HUMAN CORONAVIRUS OC43; INTENSIVE CARE; NONHUMAN; PANDEMIC; PREVALENCE; PRIORITY JOURNAL; SEASONAL VARIATION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOCIAL DISTANCE; TIME SERIES ANALYSIS; UNITED STATES; VIRUS IMMUNITY; WINTER; BETACORONAVIRUS; BIOLOGICAL MODEL; CORONAVIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; SEASON; VIROLOGY; VIRUS PNEUMONIA;

UNITED STATES;

CORONAVIRUS; SARS CORONAVIRUS;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; CORONAVIRUS OC43, HUMAN; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; MODELS, BIOLOGICAL; PANDEMICS; PNEUMONIA, VIRAL; SEASONS;

EID: 85085263731     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.abb5793     Document Type: Article

References (58)

1. World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report – 66 (WHO, 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn= 9e5b8b48_2.
2. R. Li, C. Rivers, Q. Tan, M. B. Murray, E. Toner, M. Lipsitch, The demand for inpatient and ICU beds for COVID-19 in the US: lessons from Chinese cities. medRxiv 2020.03.09.20033241 [Preprint]. 16 March 2020; https://doi.org/10.1101/2020.03.09.20033241.
3. “‘Not a wave, a tsunami.’ Italy hospitals at virus limit,” AP NEWS, 13 March 2020; https://apnews.com/ a4497f31bf5dbc1ff263e4263fc9f69e.
4. “COVID-19 infections rise in New York with peak weeks away.” AP NEWS, 25 March 2020; https://apnews.com/ 7c7563cb82626a4042797c6aa6da260a.
5. D. L. Heymann, J. S. Mackenzie, M. Peiris, Lancet 381, 779–781 (2013).
6. Centers for Disease Control and Prevention, Transcript for the CDC Telebriefing Update on COVID-19 (CDC, 2020); https://www.cdc.gov/media/releases/2020/t0225-cdctelebriefing-covid-19.html.
7. P. S. Wikramaratna, M. Sandeman, M. Recker, S. Gupta, Philos. Trans. R. Soc. B Biol. Sci. 368, 20120200 (2013).
8. L. Vijgen et al., J. Virol. 79, 1595–1604 (2005).
9. S. Su et al., Trends Microbiol. 24, 490–502 (2016).
10. M. E. Killerby et al., J. Clin. Virol. 101, 52–56 (2018).
11. R. A. Neher, R. Dyrdak, V. Druelle, E. B. Hodcroft, J. Albert, Swiss Med. Wkly. 150, w20224 (2020).
12. J. Shaman, V. E. Pitzer, C. Viboud, B. T. Grenfell, M. Lipsitch, PLOS Biol. 8, e1000316 (2010).
13. J. Shaman, E. Goldstein, M. Lipsitch, Am. J. Epidemiol. 173, 127–135 (2011).
14. I. Chattopadhyay, E. Kiciman, J. W. Elliott, J. L. Shaman, A. Rzhetsky, eLife 7, e30756 (2018).
15. K. A. Callow, H. F. Parry, M. Sergeant, D. A. Tyrrell, Epidemiol. Infect. 105, 435–446 (1990).
16. K.-H. Chan et al., J. Infect. 67, 130–140 (2013).
17. D. M. Patrick et al., Can. J. Infect. Dis. Med. Microbiol. 17, 330–336 (2006).
18. Z. Wu, J. M. McGoogan, JAMA 323, 1239 (2020).
19. A. Hauser, M. J. Counotte, C. C. Margossian, G. Konstantinoudis, N. Low, C. L. Althaus, J. Riou, Estimation of SARS-CoV-2 mortality
20. during the early stages of an epidemic: a modelling study in Hubei, China and northern Italy. medRxiv 2020.03.04.20031104 [Preprint]. 6 March 2020; https://doi.org/10.1101/2020.03.04. 20031104.
21. R. Verity, L. C. Okell, I. Dorigatti, P. Winskill, C. Whittaker, N. Imai, G. Cuomo-Dannenburg, H. Thompson, P. Walker, H. Fu, A. Dighe, J. Griffin, A. Cori, M. Baguelin, S. Bhatia, A. Boonyasiri, Z. M. Cucunuba, R. Fitzjohn, K. A. M. Gaythorpe, W. Green, A. Hamlet, W. Hinsley, D. Laydon, G. Nedjati-Gilani, S. Riley, S. van-Elsand, E. Volz, H. Wang, Y. Wang, X. Xi, C. Donnelly, A. Ghani, N. Ferguson, Estimates of the severity of COVID-19 disease. medRxiv 2020.03.09.20033357 [Preprint]. 13 March 2020; https://doi.org/10.1101/2020.03.09.20033357.
22. L. Ferretti et al., Science eabb6936 (2020).
23. R. M. Anderson, H. Heesterbeek, D. Klinkenberg, T. D. Hollingsworth, Lancet 395, 931–934 (2020).
24. Q. Bi, Y. Wu, S. Mei, C. Ye, X. Zou, Z. Zhang, X. Liu, L. Wei, S. A. Truelove, T. Zhang, W. Gao, C. Cheng, X. Tang, X. Wu, Y. Wu, B. Sun, S. Huang, Y. Sun, J. Zhang, T. Ma, J. Lessler, T. Feng, Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts. medRxiv 2020.03.03.20028423 [Preprint]. 27 March 2020; https://doi.org/10.1101/2020.03.03.20028423.
25. N. Thakkar, R. Burstein, H. Hu, P. Selvaraj, D. Klein, Institute for Disease Modeling, Bill & Melinda Gates Foundation, Social distancing and mobility reductions have reduced COVID-19 transmission in King County, WA (Institute for Disease Modeling, 2020); https://covid.idmod.org/data/Social_distancing_mobility_reductions_reduced_COVID_Seattle.pdf.
26. S. Lai, N. W. Ruktanonchai, L. Zhou, O. Prosper, W. Luo, J. R. Floyd, A. Wesolowski, M. Santillana, C. Zhang, X. Du, H. Yu, A. J. Tatem, Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China. medRxiv 10.1101/2020.03.03.20029843 [Preprint]. 13 March 2020; https://doi.org/10.1101/2020.03.03.20029843.
27. N. M. Ferguson, D. Laydon, G. Nedjati-Gilani, N. Imai, K. Ainslie, M. Baguelin, S. Bhatia, A. Boonyasiri, Z. Cucunubá, G. Cuomo-Dannenburg, A. Dighe, H. Fu, K. Gaythorpe, H. Thompson, R. Verity, E. Volz, H. Wang, Y. Wang, P. G. Walker, C. Walters, P. Winskill, C. Whittaker, C. A. Donnelly, S. Riley, A. C. Ghani, Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand (Imperial College COVID-19 Response Team, 2020); https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/ gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf.
28. “Coronavirus: Thousands of extra hospital beds and staff,” BBC News, 21 March 2020; https://www.bbc.com/news/ uk-51989183.
29. C. Chen, B. Zhao, J. Hosp. Infect. S0195-6701(20)30107-9 (2020).
30. “Pentagon says it will give 5 million respirators, 2,000 ventilators to Health and Human Services for virus response,” AP NEWS, 17 March 2020; https://apnews.com/ 79e98812b5b1592a134803b00c8d88b0.
31. “Coronavirus: How can China build a hospital so quickly?” BBC News, 31 January 2020; https://www.bbc.com/news/ world-asia-china-51245156.
32. Centers for Disease Control and Prevention, The National Respiratory and Enteric Virus Surveillance System (NREVSS) (CDC, 2020); https://www.cdc.gov/surveillance/nrevss/index. html.
33. E. Goldstein, S. Cobey, S. Takahashi, J. C. Miller, M. Lipsitch, PLOS Med. 8, e1001051 (2011).
34. Centers for Disease Control and Prevention, FluView Interactive (CDC, 2018); https://www.cdc.gov/flu/weekly/fluviewinteractive.htm.
35. J. Wallinga, P. Teunis, Am. J. Epidemiol. 160, 509–516 (2004).
36. J. Wallinga, M. Lipsitch, Proc. Biol. Sci. 274, 599–604 (2007).
37. D. E. te Beest, M. van Boven, M. Hooiveld, C. van den Dool, J. Wallinga, Am. J. Epidemiol. 178, 1469–1477 (2013).
38. J. M. Read, J. R. Bridgen, D. A. Cummings, A. Ho, C. P. Jewell, Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv 10.1101/2020.01.23.20018549 [Preprint]. 28 January 2020; https://doi.org/10.1101/2020.01.23.20018549.
39. S. A. Lauer et al., Ann. Intern. Med. (2020).
40. N. M. Linton et al., J. Clin. Med. 9, 538 (2020).
41. World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report – 51 (WHO, 2020); www.who.int/ docs/default-source/coronaviruse/situation-reports/ 20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.
42. Q. Li et al., N. Engl. J. Med. 382, 1199–1207 (2020).
43. A. Handel, I. M. Longini Jr., R. Antia, Proc. Biol. Sci. 274, 833–837 (2007).
44. C. M. Peak, R. Kahn, Y. H. Grad, L. M. Childs, R. Li, M. Lipsitch, C. O. Buckee, Modeling the comparative impact of individual quarantine vs. active monitoring of contacts for the mitigation of COVID-19. medRxiv 10.1101/2020.03.05.20031088 [Preprint]. 8 March 2020; https://doi.org/10.1101/2020.03.05.20031088.
45. R. J. Hatchett, C. E. Mecher, M. Lipsitch, Proc. Natl. Acad. Sci. U.S.A. 104, 7582–7587 (2007).
46. K. E. Huang, M. Lipsitch, J. Shaman, E. Goldstein, Epidemiology 25, 203–206 (2014).
47. J. Shaman, M. Galanti, Direct measurement of rates of asymptomatic infection and clinical care-seeking for seasonal coronavirus. medRxiv 10.1101/2020.01.30.20019612 [Preprint]. 3 February 2020; https://doi.org/10.1101/2020.01.30.20019612.
48. James Cook University, State of the Tropics 2017 Report: Sustainable Infrastructure in the Tropics (James Cook University, 2017); https://www.jcu.edu.au/state-of-thetropics/publications/2017.
49. D. He et al., Sci. Rep. 5, 11013 (2015).
50. K. S. Vannice et al., Vaccine 37, 863–868 (2019).
51. R. Li et al., Science eabb3221 (2020).
52. J. A. Tetro, Microbes Infect. 22, 72–73 (2020).
53. Y. Fu, Y. Cheng, Y. Wu, Virol. Sin. (2020).
54. M. U. G. Kraemer et al., Science 368, eabb4218 (2020).
55. M. Lipsitch, C. Viboud, Proc. Natl. Acad. Sci. U.S.A. 106, 3645–3646 (2009).
56. H. V. Fineberg, N. Engl. J. Med. (2020).
57. C. Tedijanto, c2-d2/CoV-seasonality: First release, Zenodo (2020); https://zenodo.org/record/3726085#. XpC68_7twwk.
58. S. Kissler, nCoV_introduction, Version 4.0, Zenodo (2020); https://zenodo.org/record/3745557#.XpC7Y_7twwk.